0.571

4.83% -0.029

Traws Pharma Inc (TRAW)

Overview News Price History Discussions Forecast

Traws Pharma Inc stock is traded at $0.571, with a volume of 75,274. It is down -4.83% in the last 24 hours and down -18.98% over the past month. Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib. The company has four clinical programs: (i) tivoxavir marboxil, (ii) ratutrelvir, (iii) narazaciclib (ON 123300), and (iv) rigosertib. It is focused on the development of tivoxavir marboxil and ratutrelvir. The company derives revenue from its collaboration and licensing agreements.

Previous Close:

$0.60

Open:

$0.607

24h Volume:

75,274

Relative Volume:

0.18

Market Cap:

$8.70M

Revenue:

$2.73M

Net Income/Loss:

$-19.43M

P/E Ratio:

-0.2511

EPS:

-2.2739

Net Cash Flow:

$-17.91M

1W Performance:

+7.33%

1M Performance:

-18.98%

6M Performance:

-70.26%

1Y Performance:

-64.75%

1-Day Range:

$0.57

$0.6165

1-Week Range:

$0.53

$0.6165

52-Week Range:

$0.4301

$3.265

Traws Pharma Inc Stock (TRAW) Company Profile

Name

Traws Pharma Inc

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

267-759-3680

Address

12 PENNS TRAIL, NEWTOWN

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

TRAW's Discussions on Twitter

Compare TRAW vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TRAW Traws Pharma Inc	0.571	8.12M	2.73M	-19.43M	-17.91M	-2.2739
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Traws Pharma Inc Stock (TRAW) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-03-25	Initiated	H.C. Wainwright	Buy
Mar-01-22	Initiated	Ladenburg Thalmann	Buy
May-18-21	Initiated	Guggenheim	Buy
Mar-01-18	Reiterated	H.C. Wainwright	Buy
Jan-17-18	Downgrade	Maxim Group	Buy → Hold
Oct-09-17	Initiated	H.C. Wainwright	Buy
Apr-27-17	Initiated	Laidlaw	Buy
Jul-01-15	Upgrade	Piper Jaffray	Neutral → Overweight
May-05-15	Initiated	H.C. Wainwright	Buy

View All

Traws Pharma Inc Stock (TRAW) Latest News

Aug 14, 2026

Ikarian Capital (TRAW) reports 1.56M-share, 9.5% beneficial stake in Traws Pharma - Stock Titan

Aug 14, 2026

Traws Pharma Flags Cash Runway Risk Into Q1 2027 Amid FDA Clinical Hold - Minichart

Aug 14, 2026

Traws Pharma Reports Q2 Results, Influenza Program Advances - TipRanks

Aug 14, 2026

Traws Pharma Q2 Results: EPS beats estimate, losses widen 45% YoY - scanx.trade

Aug 14, 2026

Traws Pharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 14, 2026

Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights - The Manila Times

Aug 14, 2026

Traws Pharma Q2 revenue falls to zero on licensing termination; net loss widens - TradingView

Aug 14, 2026

Traws Pharma Reports Q2 2026 Net Loss of $3.0 Million - Quiver Quantitative

Aug 14, 2026

Traws Pharma Expects Q3 Resubmission for Flu Antiviral - Stock Titan

Aug 14, 2026

Traws Pharma (TRAW) investor Squadron reports 0% beneficial ownership in 13G/A - Stock Titan

Aug 14, 2026

Sirenia Capital (TRAW) discloses warrant-based stake capped at 9.9% ownership - Stock Titan

Aug 14, 2026

Aug 13, 2026

Traws Pharma Inc (NASDAQ: TRAW) Share Price, TRAW Stock News, TRAW Share Price & Updates - Kalkine

Aug 13, 2026

Aug 12, 2026

Adage Capital reports 4.79% Traws Pharma (TRAW) stake totaling 730,000 shares - Stock Titan

Aug 12, 2026

Aug 10, 2026

Why Did TRAW Stock Slump 28% After Hours? - Stocktwits

Aug 10, 2026

Traws Pharma Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView

Aug 10, 2026

Aug 09, 2026